Hangzhou ZeErRui Chemical Co., Ltd.
Assessed Supplier
- Assessed
Supplier - 8th
years
Assessed Supplier
Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Lab/Research institutions
Mobile:
Tel:
Fax: +86-571-57153510
URL: http://www.chinazerchem.com
Province/state: Zhejiang Province
City: Hangzhou City
Street: No 317,Jingling Road,Guali Town,Xiaoshan District
MaxCard:
Contact Suppliers
CAS NO.16682-12-5
|
Product Name |
D-ornithine HCl |
|
CAS No |
16682-12-5 |
|
Molecular Formula |
|
|
Molecular Weight |
168.62 |
|
Manufacturing date |
20190402 |
|
Batch No |
ZERDOH20190402 |
D-Ornithine monohydrochloride is the monohydrochloride form of D-Ornithine. D-ornithine is a non-proteinogenic amino acid involved in the urea cycle by the splitting off of urea from arginine. Ornithine supplementation can attenuate fatigue in increasing the efficiency of energy consumption and promoting the excretion of ammonia.
The D-enatiomer and putative metabolite of the non-essential amino acid L-Orthinine. Stress response studies show intracerebroventricular D-Ornithine Hydrochloride weakly attenuated stress response in neonatal chick under acute stressful condition.
|
Index Name |
Specification |
Result |
|
Appearance |
White crystal or crystalline powder |
White crystalline powder |
|
Identification |
HPLC retention time correspond to WRS |
Conforms |
|
Specific rotation[α]20D |
- 18.0°~ - 23.0°(C=2 in 5N HCl) |
-22.6° |
|
Heavy metals(Pb) |
≤15ppm |
＜15ppm |
|
Loss on drying |
≤0.50% |
0.10% |
|
Residue on ignition |
≤0.20% |
0.15% |
|
L-Ornithine HCl |
≤0.50% |
0.38% |
|
Purity(HPLC) |
99.5% min |
100.14% |
|
Conclusion |
Conforms to the standard of enterprise |
|
Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization. Starting from the advantages of combining technology research and stable production, Lead Biotech cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.
It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.
